1. Home
  2. DGICB vs CTKB Comparison

DGICB vs CTKB Comparison

Compare DGICB & CTKB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DGICB

Donegal Group Inc. Class B

HOLD

Current Price

$17.69

Market Cap

565.4M

Sector

Finance

ML Signal

HOLD

Logo Cytek Biosciences Inc.

CTKB

Cytek Biosciences Inc.

HOLD

Current Price

$4.51

Market Cap

652.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DGICB
CTKB
Founded
1986
1990
Country
United States
United States
Employees
851
N/A
Industry
Property-Casualty Insurers
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
565.4M
652.1M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
DGICB
CTKB
Price
$17.69
$4.51
Analyst Decision
Hold
Analyst Count
0
4
Target Price
N/A
$5.63
AVG Volume (30 Days)
2.0K
650.1K
Earning Date
04-23-2026
05-07-2026
Dividend Yield
3.72%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$193,015,000.00
Revenue This Year
$2.26
$5.42
Revenue Next Year
N/A
$7.03
P/E Ratio
$8.06
N/A
Revenue Growth
N/A
17.67
52 Week Low
$13.84
$2.37
52 Week High
$20.30
$6.18

Technical Indicators

Market Signals
Indicator
DGICB
CTKB
Relative Strength Index (RSI) 56.64 53.77
Support Level $15.57 $3.81
Resistance Level $17.80 $4.60
Average True Range (ATR) 0.57 0.20
MACD 0.21 0.02
Stochastic Oscillator 66.75 69.86

Price Performance

Historical Comparison
DGICB
CTKB

About DGICB Donegal Group Inc. Class B

Donegal Group Inc is an insurance holding company that offers businesses and individuals personal and commercial lines of property and casualty insurance. The company's reportable segments are its Investment function, Personal lines of insurance, and Commercial lines of insurance. Personal lines products consist mainly of homeowners and private passenger automobile policies. The Commercial lines products of its insurance subsidiaries consist mainly of commercial automobile, commercial multi-peril, and workers' compensation policies. The group mainly operates in the United States.

About CTKB Cytek Biosciences Inc.

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.

Share on Social Networks: